The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Carboplatin API Market Research Report 2025
Synopsis
It is an anti-tumor API with the appearance of transparent crystalline powder, the molecular formula is C6H12N2O4Pt, and CAS number is 41575-94-4.
The global Carboplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Carboplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carboplatin API.
Report Scope
The Carboplatin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carboplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carboplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Umicore
Tapi Teva
Vinkem Labs
Cipla
Chem Genix
Fresenius Kabi Oncology
Heraeus
Johson Matthey
Qilu Pharmaceutial
Hangzhou Longshine Bio-Tech
Acebright
Kunming Guiyan Pharmaceutical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Carboplatin Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carboplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Carboplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Carboplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
It is an anti-tumor API with the appearance of transparent crystalline powder, the molecular formula is C6H12N2O4Pt, and CAS number is 41575-94-4.
The global Carboplatin API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Carboplatin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Carboplatin API.
Report Scope
The Carboplatin API market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Carboplatin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Carboplatin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Umicore
Tapi Teva
Vinkem Labs
Cipla
Chem Genix
Fresenius Kabi Oncology
Heraeus
Johson Matthey
Qilu Pharmaceutial
Hangzhou Longshine Bio-Tech
Acebright
Kunming Guiyan Pharmaceutical
Segment by Type
Purity ≥ 98 %
Purity ≥ 99 %
Segment by Application
Carboplatin Injection
Other
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Carboplatin API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Carboplatin API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Carboplatin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Carboplatin API Market Overview
1.1 Product Definition
1.2 Carboplatin API Segment by Type
1.2.1 Global Carboplatin API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Purity ≥ 98 %
1.2.3 Purity ≥ 99 %
1.3 Carboplatin API Segment by Application
1.3.1 Global Carboplatin API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Carboplatin Injection
1.3.3 Other
1.4 Global Market Growth Prospects
1.4.1 Global Carboplatin API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Carboplatin API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Carboplatin API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Carboplatin API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Carboplatin API Production Market Share by Manufacturers (2019-2024)
2.2 Global Carboplatin API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Carboplatin API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Carboplatin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Carboplatin API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Carboplatin API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Carboplatin API, Product Offered and Application
2.8 Global Key Manufacturers of Carboplatin API, Date of Enter into This Industry
2.9 Carboplatin API Market Competitive Situation and Trends
2.9.1 Carboplatin API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Carboplatin API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Carboplatin API Production by Region
3.1 Global Carboplatin API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Carboplatin API Production Value by Region (2019-2030)
3.2.1 Global Carboplatin API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Carboplatin API by Region (2025-2030)
3.3 Global Carboplatin API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Carboplatin API Production by Region (2019-2030)
3.4.1 Global Carboplatin API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Carboplatin API by Region (2025-2030)
3.5 Global Carboplatin API Market Price Analysis by Region (2019-2024)
3.6 Global Carboplatin API Production and Value, Year-over-Year Growth
3.6.1 North America Carboplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Carboplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Carboplatin API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Carboplatin API Production Value Estimates and Forecasts (2019-2030)
4 Carboplatin API Consumption by Region
4.1 Global Carboplatin API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Carboplatin API Consumption by Region (2019-2030)
4.2.1 Global Carboplatin API Consumption by Region (2019-2024)
4.2.2 Global Carboplatin API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Carboplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Carboplatin API Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Carboplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Carboplatin API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Carboplatin API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Carboplatin API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Carboplatin API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Carboplatin API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Carboplatin API Production by Type (2019-2030)
5.1.1 Global Carboplatin API Production by Type (2019-2024)
5.1.2 Global Carboplatin API Production by Type (2025-2030)
5.1.3 Global Carboplatin API Production Market Share by Type (2019-2030)
5.2 Global Carboplatin API Production Value by Type (2019-2030)
5.2.1 Global Carboplatin API Production Value by Type (2019-2024)
5.2.2 Global Carboplatin API Production Value by Type (2025-2030)
5.2.3 Global Carboplatin API Production Value Market Share by Type (2019-2030)
5.3 Global Carboplatin API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Carboplatin API Production by Application (2019-2030)
6.1.1 Global Carboplatin API Production by Application (2019-2024)
6.1.2 Global Carboplatin API Production by Application (2025-2030)
6.1.3 Global Carboplatin API Production Market Share by Application (2019-2030)
6.2 Global Carboplatin API Production Value by Application (2019-2030)
6.2.1 Global Carboplatin API Production Value by Application (2019-2024)
6.2.2 Global Carboplatin API Production Value by Application (2025-2030)
6.2.3 Global Carboplatin API Production Value Market Share by Application (2019-2030)
6.3 Global Carboplatin API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Umicore
7.1.1 Umicore Carboplatin API Corporation Information
7.1.2 Umicore Carboplatin API Product Portfolio
7.1.3 Umicore Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Umicore Main Business and Markets Served
7.1.5 Umicore Recent Developments/Updates
7.2 Tapi Teva
7.2.1 Tapi Teva Carboplatin API Corporation Information
7.2.2 Tapi Teva Carboplatin API Product Portfolio
7.2.3 Tapi Teva Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Tapi Teva Main Business and Markets Served
7.2.5 Tapi Teva Recent Developments/Updates
7.3 Vinkem Labs
7.3.1 Vinkem Labs Carboplatin API Corporation Information
7.3.2 Vinkem Labs Carboplatin API Product Portfolio
7.3.3 Vinkem Labs Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Vinkem Labs Main Business and Markets Served
7.3.5 Vinkem Labs Recent Developments/Updates
7.4 Cipla
7.4.1 Cipla Carboplatin API Corporation Information
7.4.2 Cipla Carboplatin API Product Portfolio
7.4.3 Cipla Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Cipla Main Business and Markets Served
7.4.5 Cipla Recent Developments/Updates
7.5 Chem Genix
7.5.1 Chem Genix Carboplatin API Corporation Information
7.5.2 Chem Genix Carboplatin API Product Portfolio
7.5.3 Chem Genix Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Chem Genix Main Business and Markets Served
7.5.5 Chem Genix Recent Developments/Updates
7.6 Fresenius Kabi Oncology
7.6.1 Fresenius Kabi Oncology Carboplatin API Corporation Information
7.6.2 Fresenius Kabi Oncology Carboplatin API Product Portfolio
7.6.3 Fresenius Kabi Oncology Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Fresenius Kabi Oncology Main Business and Markets Served
7.6.5 Fresenius Kabi Oncology Recent Developments/Updates
7.7 Heraeus
7.7.1 Heraeus Carboplatin API Corporation Information
7.7.2 Heraeus Carboplatin API Product Portfolio
7.7.3 Heraeus Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Heraeus Main Business and Markets Served
7.7.5 Heraeus Recent Developments/Updates
7.8 Johson Matthey
7.8.1 Johson Matthey Carboplatin API Corporation Information
7.8.2 Johson Matthey Carboplatin API Product Portfolio
7.8.3 Johson Matthey Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Johson Matthey Main Business and Markets Served
7.7.5 Johson Matthey Recent Developments/Updates
7.9 Qilu Pharmaceutial
7.9.1 Qilu Pharmaceutial Carboplatin API Corporation Information
7.9.2 Qilu Pharmaceutial Carboplatin API Product Portfolio
7.9.3 Qilu Pharmaceutial Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Qilu Pharmaceutial Main Business and Markets Served
7.9.5 Qilu Pharmaceutial Recent Developments/Updates
7.10 Hangzhou Longshine Bio-Tech
7.10.1 Hangzhou Longshine Bio-Tech Carboplatin API Corporation Information
7.10.2 Hangzhou Longshine Bio-Tech Carboplatin API Product Portfolio
7.10.3 Hangzhou Longshine Bio-Tech Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Hangzhou Longshine Bio-Tech Main Business and Markets Served
7.10.5 Hangzhou Longshine Bio-Tech Recent Developments/Updates
7.11 Acebright
7.11.1 Acebright Carboplatin API Corporation Information
7.11.2 Acebright Carboplatin API Product Portfolio
7.11.3 Acebright Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Acebright Main Business and Markets Served
7.11.5 Acebright Recent Developments/Updates
7.12 Kunming Guiyan Pharmaceutical
7.12.1 Kunming Guiyan Pharmaceutical Carboplatin API Corporation Information
7.12.2 Kunming Guiyan Pharmaceutical Carboplatin API Product Portfolio
7.12.3 Kunming Guiyan Pharmaceutical Carboplatin API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Kunming Guiyan Pharmaceutical Main Business and Markets Served
7.12.5 Kunming Guiyan Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Carboplatin API Industry Chain Analysis
8.2 Carboplatin API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Carboplatin API Production Mode & Process
8.4 Carboplatin API Sales and Marketing
8.4.1 Carboplatin API Sales Channels
8.4.2 Carboplatin API Distributors
8.5 Carboplatin API Customers
9 Carboplatin API Market Dynamics
9.1 Carboplatin API Industry Trends
9.2 Carboplatin API Market Drivers
9.3 Carboplatin API Market Challenges
9.4 Carboplatin API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
